Syneron Medical Ltd (ELOS) Tops Q3 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/6/2026
- S&P 500, Nasdaq close sharply higher as Broadcom rallies
- Oil prices settle at pre-Iran war levels as crude output grows
- Broadcom stock pops 4% as Apple silicon deal gets extended through 2031
- Buy the pullback in chip stocks, JPM's Matejka says
- Memory stocks rebound as analysts flag a buying opportunity
- Nokia OYJ (NOKIA:FH) (NOK) PT Raised to EUR14 at Kepler Cheuvreux
- Dara Khosrowshahi steps down from Grab Holdings board
- Broadcom secures role as key Apple supplier with chip deal through 2031
- Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
- S&P 500, Nasdaq close sharply higher as Broadcom rallies
Syneron Medical Reports Third Quarter 2016 Revenue of $71.5 Million
November 9, 2016 7:01 AM ESTIRVINE, Calif., Nov. 9, 2016 /PRNewswire/ --Â Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced financial results for the three month period ended September 30, 2016.
Third Quarter 2016 Financial Highlights:
Revenue of $71.5 million, up 15.3% year-over-year Product revenue up 18.6% year-over-year, including 19.5% North America and 18.1% international growth Emerging products revenue of $24.1 million, which represents the Company's strategic growth drivers, grew 61% year-over-year Total Body Shaping revenue of $14.2 million grew 46% year-over-year GAAP earnings per share of $0.02, compared to GAAP loss per... More